|
The 15-gene expression profile test is independent from PRAME and 7-gene next-generation sequencing: Results from 3,267 clinically tested uveal melanomas. |
| |
|
Employment - Castle Biosciences |
Stock and Other Ownership Interests - Castle Biosciences |
Patents, Royalties, Other Intellectual Property - Castle Biosciences related patents |
Travel, Accommodations, Expenses - Castle Biosciences |
| |
|
No Relationships to Disclose |
| |
|
Employment - Castle Biosciences |
Stock and Other Ownership Interests - Castle Biosciences |
| |
|
Employment - Castle Biosciences |
Leadership - Castle Biosciences |
Stock and Other Ownership Interests - Castle Biosciences; Castle Biosciences (I) |
Research Funding - Castle Biosciences |
| |
|
Employment - Castle Biosciences |
Stock and Other Ownership Interests - Castle Biosciences |
Research Funding - Castle Biosciences |